Detalles de la búsqueda
1.
Dysregulation of early gene response to a mixed meal in skeletal muscle in obesity and type 2 diabetes.
Physiol Genomics
; 55(10): 468-477, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545425
2.
Visceral mesenchymal stem cells from type 2 diabetes donors activate triglycerides synthesis in healthy adipocytes via metabolites exchange and cytokines secretion.
Int J Obes (Lond)
; 47(8): 732-742, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37100877
3.
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.
Diabetes Obes Metab
; 25(7): 1890-1899, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906837
4.
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Diabetes Obes Metab
; 25(1): 46-55, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111434
5.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Am Heart J
; 243: 232-239, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34666013
6.
Three-year progress report of Bone Health TeleECHO Moscow: a strategy to improve the care of patients with osteoporosis and other metabolic skeletal diseases in underserved communities of Russia.
Osteoporos Int
; 33(9): 2035-2040, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35593943
7.
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study.
Diabetes Obes Metab
; 24(9): 1734-1740, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35546275
8.
Associations between second-line glucose-lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose-lowering treatment intensification: The DISCOVER study.
Diabetes Obes Metab
; 23(8): 1823-1833, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852202
9.
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.
Diabetes Obes Metab
; 23(10): 2336-2343, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34212481
10.
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(8): 1956-1960, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852196
11.
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(1): 39-48, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32845558
12.
Direct Effect of the Synthetic Analogue of Glucagon-Like Peptide Type 1, Liraglutide, on Mature Adipocytes Is Realized through Adenylate-Cyclase-Dependent Enhancing of Insulin Sensitivity.
Biochemistry (Mosc)
; 86(3): 350-360, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838634
13.
AICAR Protects Vascular Endothelial Cells from Oxidative Injury Induced by the Long-Term Palmitate Excess.
Int J Mol Sci
; 23(1)2021 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008640
14.
Correction to: Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS).
Diabetologia
; 63(5): 1088-1089, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32140743
15.
Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS).
Diabetologia
; 63(4): 711-721, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31901950
16.
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 22(1): 66-78, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31468637
17.
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 21(11): 2474-2485, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31297947
18.
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Cardiovasc Diabetol
; 17(1): 150, 2018 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30486889
19.
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
Diabetes Obes Metab
; 20(2): 427-437, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28834075
20.
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Diabetes Obes Metab
; 20(2): 389-399, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28817227